Promaxo Announces Clinical Collaboration with Mount Sinai Health System and UTHealth Houston
Retrieved on:
Thursday, February 16, 2023
Ketan, Prostate, Hospital, Mount Sinai Health System, Gold, Memorial Hermann–Texas Medical Center, Icahn School of Medicine at Mount Sinai, University, Nanoparticle, MRI, Pelvis, Patient, Division, Prostate cancer, Robot Operating System, Professor, AI, McGovern Medical School, James Whale Fund for Kidney Cancer, FDA, Pelvic floor, Society, Kidney, Texas Medical Center, Robotics, Mount Sinai, ASCO, Medical imaging, Urology
OAKLAND, Calif., Feb. 16, 2023 (GLOBE NEWSWIRE) -- Promaxo, Inc. (“Promaxo” or the “Company”), a medical imaging, robotics, and AI technology company, today announced clinical collaborations with Mount Sinai Health System, NY and UTHealth Houston, the University of Texas Health Science Center at Houston, TX.
Key Points:
- OAKLAND, Calif., Feb. 16, 2023 (GLOBE NEWSWIRE) -- Promaxo, Inc. (“Promaxo” or the “Company”), a medical imaging, robotics, and AI technology company, today announced clinical collaborations with Mount Sinai Health System, NY and UTHealth Houston, the University of Texas Health Science Center at Houston, TX.
- Dr. Ketan Badani, Professor of Urology at the Icahn School of Medicine at Mount Sinai and Vice Chairman of Urology and Robotic Operations at the Mount Sinai Health System, said, “At Mount Sinai, we seek to improve the detection and treatment of cancers of the prostate and kidney with less invasive and effective technology.
- " The Mount Sinai Health System is a network of eight hospital campuses in New York City.
- Located in the Texas Medical Center, UTHealth Houston is considered the largest medical center in the world.